The trademark application TARGED TARGETED ENZYME DELIVERY was filed by TargED Biopharmaceuticals B.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). Application under examination.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations
Medical preparations
Dietary supplements for medical purposes
Medicinal herbs and extracts
Drugs for medical purposes, pharmaceutical preparations for the prevention and treatment of thrombosis
Antithrombotic agents
Thrombolytic drugs
Coagulation inhibitors
Anticoagulants
Platelet aggregation inhibitors
Hemostatic agents
Blood thinners for medical use
Therapeutic compounds for thrombosis
Pharmaceutical preparations for cardiovascular diseases
Pharmaceutical preparations for blood clotting disorders
Injectable or intravenous solutions for thrombosis treatment
Medicinal products for the treatment of deep vein thrombosis (DVT)
Medicinal products for pulmonary embolism (PE) management
Preclinical or clinical trial medicines for thrombosis research
Pharmaceuticals for vascular diseases.
The mark was filed in class 42 with following description of goods:
Scientific and technological services
Research and development services
Laboratory and clinical testing
Biotechnology research services
Pharmaceutical research services
Medical and scientific laboratory services
Medical research and development services
Research and development in the field of thrombosis treatment
Pharmaceutical and biotechnology research for antithrombotic drugs
Preclinical and clinical testing of drugs for thrombosis
Drug discovery services related to thrombosis
Development of biopharmaceuticals for cardiovascular diseases
Research in the field of platelet aggregation inhibitors
Consultancy services in pharmaceutical research and development
Scientific studies related to thrombosis and blood clotting disorders
Clinical trials for thrombosis drugs and therapies
Design and implementation of drug efficacy studies for thrombosis treatment
Genetic research and molecular biology services related to thrombosis
Data analysis and modeling for thrombosis treatments
Laboratory services for thrombosis diagnosis and testing
Research services related to anticoagulation therapy
Research in personalized medicine for thrombosis patients
Services related to regulatory compliance for drug development in thrombosis
Research and development services for biotechnological solutions for thrombosis
Scientific advisory and consultation services in thrombosis research.